Artielle ImmunoTherapeutics Inc.
|
|
|
|
|
focused on a new proprietary class of molecules known as Recombinant T cell receptor Ligands (RTLs) that can be tailored to treat a wide range of autoimmune inflammatory diseases | |
Korean Distributor : ??? |
Products information :
|
|
|
|
|
|
|
|
|
|